Discovery and Validation of Methylated DNA Markers From Pancreatic Neuroendocrine Tumors.

Autor: Majumder S; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota., Halfdanarson TR; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota., Berger CK; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota., Foote PH; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota., Cao X; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota., McGlinch MC; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota., Gysbers BJ; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota., de La Fuente J; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota., Robran MJ; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota., Doering KA; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota., Burger KN; Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, Minnesota., Bamlet WE; Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, Minnesota., Oberg AL; Division of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota., Mahoney DW; Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, Minnesota., Graham RP; Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota., Taylor WR; Division of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota., Petersen GM; Division of Epidemiology, Mayo Clinic, Rochester, Minnesota., Kisiel JB; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

Publikováno v: Gastro hep advances [Gastro Hep Adv] 2022 Apr 02; Vol. 1 (3), pp. 409-416. Date of Electronic Publication: 2022 Apr 02 (Print Publication: 2022).